...
首页> 外文期刊>Japanese Journal of Pharmacology >ANTAGONIZING SUBSTANCES OBTAINED FROM WHALE HEART EXTRACT TO VASOPRESSIN INDUCED MYOCARDIAL HYPOXIA
【24h】

ANTAGONIZING SUBSTANCES OBTAINED FROM WHALE HEART EXTRACT TO VASOPRESSIN INDUCED MYOCARDIAL HYPOXIA

机译:从鲸心提取物到血管加压素诱导的心肌缺氧所获得的拮抗物质

获取原文

摘要

References(27) Cited-By(18) There are several reports that a protein-free extract of heart muscles from mammalian animals dilates coronary vessels (1, 2), increases the amplitude of heart (3), and improves the efficiency of contractions in heart lung preparations (4). Clinically, the extract has been used as an antianginal drug (5, 6), and a drug for heart failure contradictorily (7, 8). One of the main approaches to antianginal drugs has been studies of coronary dilators. However, the majority of pharmacological studies have been carried out in animals with a normal coronary circulation and the results obtained may not predict the status of the abnormal coronary circulation. Certainly, studies in man indicate that the coronary bed of the anginal patient is incapable of dilatation so that nitroglycerin produces no increase in coronary flow (9, 10). Furthermore, some reports show that dipyridamol having specific potent coronary vasodilating activity is not effective for angina pectoris (11-13). Thus, many other approaches have been tried to investigate antianginal drugs. Clinically, ST segment depression in electrocadiogram of patients of angina pectoris is very common phenomenon, and we consider ST segment depression in rats produced with vasopressin or adrenaline might be one of the experimental models of angina pectoris. Lindner et al. have shown that the vasopressin induced ischemia of the dog heart was improved after three daily injections of the large doses of a heart extract (14). Black have shown that oral administration of a heart extract for two weeks produced improvement on the above mentioned ischemia in rabbits (15). This paper describes a modification of similar experimental methods in rats and the identification of components which improves the ST segment depression in the heart extract.
机译:参考文献(27)Cited-By(18)有几篇报道说,哺乳动物的心肌无蛋白提取物可扩张冠状血管(1、2),增加心脏的振幅(3),并改善收缩效率在心肺制剂中(4)。临床上,该提取物已被用作抗心绞痛药物(5、6),与抗心力药物矛盾地被用作药物(7、8)。抗心绞痛药物的主要方法之一是研究冠状动脉扩张器。但是,大多数药理研究是在冠状动脉正常的动物中进行的,所获得的结果可能无法预测冠状动脉异常的状态。当然,人体研究表明,心绞痛患者的冠状动脉床无法扩张,因此硝酸甘油不会增加冠状动脉血流量(9,10)。此外,一些报告显示,具有特定的强效冠状血管舒张活性的潘生丁对心绞痛无效(11-13)。因此,已经尝试了许多其他方法来研究抗心绞痛药物。在临床上,心绞痛患者心电图的ST段压低是很普遍的现象,我们认为血管加压素或肾上腺素产生的大鼠ST段压低可能是心绞痛的实验模型之一。 Lindner等。已有研究表明,每天三次大剂量心脏提取物的注射后,血管加压素诱导的犬心脏缺血得到改善(14)。布莱克(Black)表明,口服心脏提取物两周可改善兔子的上述局部缺血(15)。本文描述了对大鼠类似实验方法的改进,并鉴定了可改善心脏提取物中ST段抑制的成分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号